Sodium stearate
Names
[ CAS No. ]:
822-16-2
[ Name ]:
Sodium stearate
[Synonym ]:
sodium,octadecanoate
Octadecanoic acid, sodium salt (1:1)
Octadecanoic acid sodium salt
octadecanoic acid, sodium salt
Sodium stearate
SODIUM OCTADECANOATE
EINECS 212-490-5
Stearic Acid, Sodium Salt
stearic acid sodium salt
MFCD00036404
Biological Activity
[Description]:
[Related Catalog]:
Chemical & Physical Properties
[ Density]:
1.103 g/cm3
[ Boiling Point ]:
359.4ºC at 760 mmHg
[ Melting Point ]:
245 - 255ºC
[ Molecular Formula ]:
C18H35NaO2
[ Molecular Weight ]:
306.459
[ Flash Point ]:
162.4ºC
[ Exact Mass ]:
306.253479
[ PSA ]:
40.13000
[ LogP ]:
4.99780
[ Storage condition ]:
2-8°C
[ Stability ]:
Stable. Incompatible with strong oxidizing agents.
[ Water Solubility ]:
SOLUBLE IN COLD AND HOT WATER
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- WI4725000
- CHEMICAL NAME :
- Stearic acid, sodium salt
- CAS REGISTRY NUMBER :
- 822-16-2
- LAST UPDATED :
- 199712
- DATA ITEMS CITED :
- 8
- MOLECULAR FORMULA :
- C18-H35-O2.Na
- MOLECULAR WEIGHT :
- 306.52
- WISWESSER LINE NOTATION :
- QV17 &-NA-
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 400 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- ATMPA2 Annals of Tropical Medicine and Parasitology. (Grune & Stratton, Inc., POB 6280, Duluth, MN 55806) V.1- 1907- Volume(issue)/page/year: 32,177,1938
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 10 mg/kg
- TOXIC EFFECTS :
- Vascular - thrombosis distant from injection site
- REFERENCE :
- JCINAO Journal of Clinical Investigation. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1924- Volume(issue)/page/year: 42,860,1963 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 10 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 69445 No. of Facilities: 8011 (estimated) No. of Industries: 75 No. of Occupations: 89 No. of Employees: 98215 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 69445 No. of Facilities: 6021 (estimated) No. of Industries: 60 No. of Occupations: 54 No. of Employees: 98046 (estimated) No. of Female Employees: 35115 (estimated)
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xn
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
UN 3077 9/PG 3
[ WGK Germany ]:
1
[ RTECS ]:
WI4725000
[ HS Code ]:
2915709000
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2915709000
[ Summary ]:
2915709000. palmitic acid and its salts and esters. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0%
Articles
J. Pharm. Sci. 103(7) , 2157-65, (2014)
The major obstacle to glioblastoma pharmacological therapy is the overcoming of the blood-brain barrier (BBB). In literature, several strategies have been proposed to overcome the BBB: in this experim...
Kinetically stable propofol emulsions with reduced free drug concentration for intravenous delivery.Int. J. Pharm. 486 , 232-41, (2015)
Intravenous injections of propofol emulsions are accompanied by pain likely due to the interaction of the dissolved drug with endothelial cells of the vasculature. It is commonly hypothesized that red...
A drug formulation using an alginate hydrogel matrix for efficient oral delivery of the manganese porphyrin-based superoxide dismutase mimic.Biomater. Sci. 3 , 861-9, (2015)
In order for patients to avail of the therapeutic benefits of antioxidant drugs efficiently and conveniently, a robust oral delivery system needs to be developed. However, a common problem in oral dru...